Associate Professor of Health Sciences Adam MacNeil at Brock University, Canada and his Ph.D. student Jeremia Coish were among the earliest to warn, last June, of the dangers of not looking very carefully at the possibility that vaccines might trigger antibody-dependent enhancement (ADE) of disease. This could mean that people who are vaccinated might, paradoxically, suffer more severe disease when exposed to the wild virus than if they hadn’t been vaccinated.
In their aptly titled article, “Out of the frying pan and into the fire? Due diligence warranted for ADE in COVID-19,” published in the journal Microbes and Infection in June 2020, MacNeil and Coish argue that ADE is well known to be a risk for coronavirus-mediated infections, as well as dengue.
For those not already familiar with ADE, it is the paradoxical immune response that makes a person who was previously exposed to the disease, or a vaccine targeting it, more — not less — susceptible in the event that they’re subsequently infected.
What Cardozo and Veazy also suggest is another point we’ve long been concerned about. That relates to the fact that trial subjects — let alone members of the public who’re now lining up for COVID vaccines — are just not being informed of these potential risks, and the delayed nature of possible ADE/VAH reactions.
Does non-disclosure as part of the informed consent process constitute not only a breach of medical ethics, but also a breach of law? In our view, that’s highly likely and should evidence accrue in the future, this will be something the courts will need to grapple with.Scientists Warn of Potential COVID Vaccine-Related ‘Ticking Time Bomb’ • Children’s Health Defense